Xavier Castellsague

Summary

Country: Spain

Publications

  1. doi High prevalence of human papillomavirus infection in the female population of Guatemala
    Xavier Valles
    Institut Catala d Oncologia, IDIBELL, L Hospitalet de Llobregat, Barcelona, Spain
    Int J Cancer 125:1161-7. 2009
  2. doi HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives
    Xavier Castellsague
    Cancer Epidemiology Research Program, Institut Catala d Oncologia, IDIBELL, CIBER ESP, Barcelona, Spain
    Gynecol Oncol 115:S15-23. 2009
  3. pmc The role of human papillomavirus in head and neck cancer in Senegal
    Cathy Ndiaye
    Department of Social and Preventive Medicine, Université de Montréal Sainte Justine Hospital Research Center, 3175 Cote Sainte Catherine, Room A 830, Montreal, QC H3T 1C5, Canada
    Infect Agent Cancer 8:14. 2013
  4. pmc Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review
    Susanne Hartwig
    Department of Epidemiology, Sanofi Pasteur MSD, Lyon, France
    BMC Cancer 12:30. 2012
  5. doi Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study
    Xavier Castellsague
    Cancer Epidemiology Research Program, Catalan Institute of Oncology IDIBELL, CIBER ESP, L Hospitalet de Llobregat, Spain
    J Med Virol 84:947-56. 2012
  6. pmc Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis
    Beibei Lu
    Risk Assessment, Detection and Intervention Program, H, Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
    BMC Infect Dis 11:13. 2011
  7. pmc Prevalence, concordance and determinants of human papillomavirus infection among heterosexual partners in a rural region in central Mexico
    Rocio Parada
    Centro de Investigacion en Salud Poblacional, Instituto Nacional de Salud Publica, Cuernavaca, Morelos, Mexico
    BMC Infect Dis 10:223. 2010
  8. pmc Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain
    Xavier Castellsague
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, IDIBELL Institut Català d Oncologia ICO, Hospitalet de Llobregat, Barcelona, Spain
    BMC Infect Dis 9:74. 2009
  9. pmc End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age
    X Castellsague
    Unit of Infections and Cancer, Cancer Epidemiology Research Program, IDIBELL, Institut Català d Oncologia ICO, CIBER ESP, L Hospitalet de Llobregat, Catalonia 08907, Spain
    Br J Cancer 105:28-37. 2011
  10. doi Natural history and epidemiology of HPV infection and cervical cancer
    Xavier Castellsague
    Unit of Infections and Cancer, Institut Catala d Oncologia, IDIBELL, CIBER ESP
    Gynecol Oncol 110:S4-7. 2008

Detail Information

Publications46

  1. doi High prevalence of human papillomavirus infection in the female population of Guatemala
    Xavier Valles
    Institut Catala d Oncologia, IDIBELL, L Hospitalet de Llobregat, Barcelona, Spain
    Int J Cancer 125:1161-7. 2009
    ..HPV and abnormal cytology prevalence is high among women in Guatemala. The introduction of a HPV vaccination program would prevent an important fraction of HPV-related disease burden...
  2. doi HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives
    Xavier Castellsague
    Cancer Epidemiology Research Program, Institut Catala d Oncologia, IDIBELL, CIBER ESP, Barcelona, Spain
    Gynecol Oncol 115:S15-23. 2009
    ..We consider oncogenic HPV infection and the risk of developing cervical cancer in women over 25 years of age and whether they would also benefit from vaccination against HPV...
  3. pmc The role of human papillomavirus in head and neck cancer in Senegal
    Cathy Ndiaye
    Department of Social and Preventive Medicine, Université de Montréal Sainte Justine Hospital Research Center, 3175 Cote Sainte Catherine, Room A 830, Montreal, QC H3T 1C5, Canada
    Infect Agent Cancer 8:14. 2013
    ..Exploring the presence and role of human papillomavirus (HPV) in head and neck cancer (HNC) is a necessary step to evaluate the potential impact of HPV prophylactic vaccines...
  4. pmc Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review
    Susanne Hartwig
    Department of Epidemiology, Sanofi Pasteur MSD, Lyon, France
    BMC Cancer 12:30. 2012
    ..The objective of this review is to estimate the epidemiological burden of HPV-related cancers and non-malignant diseases in men in Europe...
  5. doi Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study
    Xavier Castellsague
    Cancer Epidemiology Research Program, Catalan Institute of Oncology IDIBELL, CIBER ESP, L Hospitalet de Llobregat, Spain
    J Med Virol 84:947-56. 2012
    ..The high prevalence of HPV infection among young women may reflect recent changes in sexual behavior...
  6. pmc Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis
    Beibei Lu
    Risk Assessment, Detection and Intervention Program, H, Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
    BMC Infect Dis 11:13. 2011
    ..We conducted a systematic review and meta-analysis to assess efficacy and safety of prophylactic HPV vaccines against cervical cancer precursor events in women...
  7. pmc Prevalence, concordance and determinants of human papillomavirus infection among heterosexual partners in a rural region in central Mexico
    Rocio Parada
    Centro de Investigacion en Salud Poblacional, Instituto Nacional de Salud Publica, Cuernavaca, Morelos, Mexico
    BMC Infect Dis 10:223. 2010
    ..The present study determined the prevalence and concordance of type-specific HPV infection as well as the determinants of infection in heterosexual couples in a rural area of Mexico...
  8. pmc Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain
    Xavier Castellsague
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, IDIBELL Institut Català d Oncologia ICO, Hospitalet de Llobregat, Barcelona, Spain
    BMC Infect Dis 9:74. 2009
    ..Studies on HPV infection in pregnant women and HPV transmission to the child have yielded inconsistent results...
  9. pmc End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age
    X Castellsague
    Unit of Infections and Cancer, Cancer Epidemiology Research Program, IDIBELL, Institut Català d Oncologia ICO, CIBER ESP, L Hospitalet de Llobregat, Catalonia 08907, Spain
    Br J Cancer 105:28-37. 2011
    ..In this report, we present end-of-study efficacy, safety, and immunogenicity data with a median follow-up time of 4.0 years...
  10. doi Natural history and epidemiology of HPV infection and cervical cancer
    Xavier Castellsague
    Unit of Infections and Cancer, Institut Catala d Oncologia, IDIBELL, CIBER ESP
    Gynecol Oncol 110:S4-7. 2008
    ..If implemented widely and wisely the deployment of these protocols has the potential to complete Papanicolaou's goal of cervical cancer eradication by extending the benefits of prevention to the developing populations of the world...
  11. ncbi Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention
    Xavier Castellsague
    IDIBELL, Institut Català d Oncologia ICO, L Hospitalet de Llobregat, Barcelona, Spain
    Int J Cancer 122:1901-4. 2008
    ..The introduction of an efficacious HPV 16/18 vaccine could potentially prevent the occurrence of 72% of cervical cancer cases and up to 81% of the cases if full cross-protection against HPVs 31 and 45 is assumed...
  12. doi Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies
    Xavier Castellsague
    Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Catala d Oncologia, Bellvitge Biomedical Research Institute, L Hospitalet de Llobregat, Catalonia, Spain
    Lancet Oncol 12:1023-31. 2011
    ..We assessed whether IUD use affects cervical human papillomavirus (HPV) infection and the risk of developing cervical cancer...
  13. doi Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
    Silvia de Sanjose
    IDIBELL, Institut Català d Oncologia Catalan Institute of Oncology, L Hospitalet de Llobregat, Barcelona, Spain
    Lancet Oncol 11:1048-56. 2010
    ..We aimed to provide novel and comprehensive data about the worldwide genotype distribution in patients with invasive cervical cancer...
  14. ncbi Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention
    Xavier Castellsague
    Institut d Investigacio Biomedica de Bellvitge, Cancer Epidemiology and Registration Unit, Institut Català d Oncologia L Hospitalet de Llobregat, Barcelona, Spain
    J Natl Cancer Inst 98:303-15. 2006
    ..The extent to which human papillomavirus (HPV) infection and cofactors may explain this differential trend is unclear...
  15. ncbi Chlamydia trachomatis infection in female partners of circumcised and uncircumcised adult men
    Xavier Castellsague
    Cancer Epidemiology and Registration Unit, Institut d Investigacio Biomedica de Bellvitge, Institut Catala d Oncologia, L Hospitalet de Llobregat, Barcelona, Spain
    Am J Epidemiol 162:907-16. 2005
    ..These findings suggest that male circumcision could reduce the risk of C. trachomatis infection in female sexual partners...
  16. ncbi Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort
    Esther Roura
    Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology ICO IDIBELL, L Hospitalet de Llobregat, Barcelona, Catalonia, Spain CIBER de Epidemiología y Salud Pública CIBERESP, Spain
    Int J Cancer 135:453-66. 2014
    ..The strong beneficial effect of quitting smoking is an important finding that will further support public health policies for smoking cessation. ..
  17. doi Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva
    Silvia de Sanjose
    Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L Hospitalet de Llobregat, Barcelona, Spain CIBER en Epidemiología y Salud Pública CIBERESP, Barcelona, Spain Electronic address
    Eur J Cancer 49:3450-61. 2013
    ..Human papillomavirus (HPV) contribution in vulvar intraepithelial lesions (VIN) and invasive vulvar cancer (IVC) is not clearly established. This study provides novel data on HPV markers in a large series of VIN and IVC lesions...
  18. doi Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings
    Laia Bruni
    Unit of Infections and Cancer, Cancer Epidemiology Research Program, IDIBELL Institut Català d Oncologia, Barcelona, Spain
    J Infect Dis 202:1789-99. 2010
    ..Baseline information on human papillomavirus (HPV) prevalence and type distribution is highly desirable to evaluate the impact of prophylactic HPV vaccines in the near future...
  19. pmc Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study
    Esther Roura
    Cancer Epidemiology Research Program, Institut Català d Oncologia IDIBELL, CIBER ESP, RTICC, L Hospitalet de Llobregat, Barcelona, Catalonia, Spain
    BMC Infect Dis 12:145. 2012
    ..The aim of the current study was to investigate socio-demographic, lifestyle, and medical factors for potential associations with cervical HPV infection in women undergoing cervical cancer screening in Spain...
  20. doi Age at sexual initiation and number of sexual partners in the female Spanish population Results from the AFRODITA survey
    Silvia de Sanjose
    Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institut of Oncology, Hospitalet del Llobregat, Spain
    Eur J Obstet Gynecol Reprod Biol 140:234-40. 2008
    ..The AFRODITA study was designed to describe patterns relating to the number of lifetime sexual partners (SP) and age at first sexual intercourse (AFSI) by geographic region in a representative sample of Spanish women...
  21. ncbi Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
    Silvia de Sanjose
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Barcelona, Spain
    Lancet Infect Dis 7:453-9. 2007
    ..The HPV types most commonly detected are similar to those most commonly described in pre-neoplastic and cancer cases, although the relative contribution of HPV16 and HPV18 is substantially lower in cytologically normal women...
  22. doi Comprehensive control of human papillomavirus infections and related diseases
    F Xavier Bosch
    Cancer Epidemiology Research Program CERP, Institut Català d Oncologia Catalan Institute of Oncology ICO, IDIBELL, L Hospitalet de Llobregat Barcelona, Spain Electronic address
    Vaccine 31:G1-31. 2013
    ..Additional details on each subtopic and full information regarding the supporting literature references may be found in the original chapters. ..
  23. doi Comprehensive control of human papillomavirus infections and related diseases
    F Xavier Bosch
    Cancer Epidemiology Research Program CERP, Institut Català d Oncologia Catalan Institute of Oncology ICO, IDIBELL, L Hospitalet de Llobregat Barcelona, Spain Electronic address
    Vaccine 31:H1-31. 2013
    ..Additional details on each subtopic and full information regarding the supporting literature references may be found in the original chapters. ..
  24. ncbi Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort
    Xavier Castellsague
    Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology ICO IDIBELL, L Hospitalet de Llobregat, Barcelona, Catalonia, Spain CIBER de Epidemiología y Salud Pública CIBERESP, Madrid, Spain
    Int J Cancer 135:440-52. 2014
    ..It further identifies HPV16 E6 seropositivity as the strongest marker to predict ICC well before disease development. ..
  25. doi Comprehensive control of human papillomavirus infections and related diseases
    F Xavier Bosch
    Cancer Epidemiology Research Program CERP, Institut Català d Oncologia Catalan Institute of Oncology ICO, IDIBELL, L Hospitalet de Llobregat Barcelona, Spain Electronic address
    Vaccine 31:F1-31. 2013
    ..Additional details on each subtopic and full information regarding the supporting literature references may be found in the original chapters. ..
  26. ncbi Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners
    Xavier Castellsague
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Hospitalet de Llobregat, Barcelona, Spain
    N Engl J Med 346:1105-12. 2002
    ..It is uncertain whether male circumcision reduces the risks of penile human papillomavirus (HPV) infection in the man and of cervical cancer in his female partner...
  27. doi Epidemiology and costs of screening and management of precancerous lesions of the cervix in Spain
    Xavier Castellsague
    Cancer Epidemiology Research Program, Institut Catala d Oncologia, IDIBELL, CIBERESP, L Hospitalet de Llobregat, Catalonia, Spain
    J Low Genit Tract Dis 13:38-45. 2009
    ..Screening prevents cancer by detecting precancerous lesions (cervical intraepithelial neoplasia, CIN). Our aim was to assess the annual number of Pap smears and CIN diagnoses in Spain and to estimate associated management costs...
  28. ncbi Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007
    Laia Alemany
    Unit of Infections and Cancer, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain CIBER Epidemiología y Salud Pública CIBERESP, Spain
    Int J Cancer 135:88-95. 2014
    ..The observed stability on the HPV type distribution predicts a high and stable impact of HPV vaccination in reducing the cervical cancer burden in future vaccinated generations. ..
  29. doi Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in Spain
    Luis M Puig-Tintore
    Gynecologic Oncology, Hospital Clinic, University of Barcelona, Catalonia, Spain
    J Low Genit Tract Dis 12:82-9. 2008
    ..To quantify the coverage and monitor the factors associated with opportunistic cervical cytological screening in Spain...
  30. doi Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
    Cathy Ndiaye
    Department of Social and Preventive Medicine, Universite de Montreal, Montreal, QC, Canada Sainte Justine Hospital Research Center, Montreal, QC, Canada Unit of Infections and Cancer, Institut Catala d Oncologia, Barcelona, Spain CIBER Epidemiología y Salud Pública, CIBERESP, Barcelona, Spain Université Cheikh Anta Diop, Dakar, Senegal Faculté de Médecine, Université de Bamako, Bamako, Mali Hôpital Principal de Dakar, Dakar, Senegal Department of Pathology, School of Biomedical Sciences, Makerere University, Kampala, Uganda Lagos University Teaching Hospital Idi Araba, Lagos, Nigeria Red Temàtica de Investigaciòn Cooperativa en Càncer, RTICC, Barcelona, Spain
    Trop Med Int Health 17:1432-40. 2012
    ..To describe human papillomavirus (HPV) distribution in invasive cervical carcinoma (ICC) from Mali and Senegal and to compare type-specific relative contribution among sub-Saharan African (SSA) countries...
  31. pmc Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study
    Ginesa Albero
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Program CERP, Catalan Institute of Oncology ICO, L Hospitalet de Llobregat 08908, Barcelona, Spain
    BMC Infect Dis 13:18. 2013
    ..The purpose of this study was to assess the association between MC and genital HPV infection in men in a large multinational study...
  32. doi Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention
    Laia Alemany
    IDIBELL, Institut Català d Oncologia Catalan Institute of Oncology, L Hospitalet de Llobregat, Barcelona, Spain
    Gynecol Oncol 124:512-7. 2012
    ..Human papillomavirus (HPV) genotype distribution in invasive cervical cancer (ICC) is critical to guide the introduction and to assess the impact of HPV prophylactic vaccines. This study aims to provide specific information for Spain...
  33. ncbi Environmental co-factors in HPV carcinogenesis
    Xavier Castellsague
    Servei d Epidemiologia i Registre del Cancer, Institut Catala d Oncologia, Gran Vias n km 2, 7 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Virus Res 89:191-9. 2002
    ....
  34. ncbi The male role in cervical cancer
    Xavier Castellsague
    Institut Catala d Oncologia, Servel d Epidemiologia I Registre del Càncer, Gran Via s n, Km 2 7, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Salud Publica Mex 45:S345-53. 2003
    ..More research is needed to better understand the natural history and epidemiology of HPV infections in men. This paper is available too at: http://www.insp.mx/salud/index.html...
  35. ncbi Human papillomavirus vaccines and vaccine implementation
    Silvia de Sanjose
    Unit of Infections and Cancer UNIC, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL and CIBER Epidemiología y Salud Pública CIBERESP, Barcelona, Spain
    Womens Health (Lond Engl) 4:595-604. 2008
    ..Finally, some major aspects that are likely to impact the introduction of these vaccines around the world are outlined, with particular emphasis on developing countries...
  36. doi Male circumcision and genital human papillomavirus: a systematic review and meta-analysis
    Ginesa Albero
    Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d Oncologia Catalan Institute of Oncology, L Hospitalet de Llobregat, Barcelona, Spain
    Sex Transm Dis 39:104-13. 2012
    ..The purpose of this study was to conduct a systematic review of the literature to assess the association between MC and genital HPV infection indicators including genital warts...
  37. pmc Comprehensive control of human papillomavirus infections and related diseases
    F Xavier Bosch
    Cancer Epidemiology Research Program CERP, Institut Català d Oncologia Catalan Institute of Oncology ICO, IDIBELL, L Hospitalet de Llobregat Barcelona, Spain Electronic address
    Vaccine 31:I1-31. 2013
    ..Additional details on each subtopic and full information regarding the supporting literature references may be found in the original chapters. ..
  38. ncbi The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis
    Xavier Castellsague
    Institut Catala d Oncologia, Servei d Epidemiologia i Registre del Cancer, L Hospitalet de Llobregat, Barcelona, Spain
    Int J Cancer 108:741-9. 2004
    ..These results underline the importance of type of tobacco and alcohol concentration in oral carcinogenesis...
  39. ncbi The prospects of HPV vaccination in cervical cancer prevention: results of a new independent trial
    F Xavier Bosch
    Cancer Epidemiology Research Program CERP, Catalan Institute of Oncology Institut Català d Oncologia ICO and Bellvitge Biomedical Research Institute, Avenida Gran Via 199 203, L Hospitalet de Llobregat, Barcelona, Spain
    Cancer Discov 1:377-80. 2011
    ....
  40. ncbi The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence
    Reina Garcia-Closas
    Cancer Epidemiology and Registration Unit, Institut Català d Oncologia ICO, L Hospitalet de Llobregat, Barcelona, Spain
    Int J Cancer 117:629-37. 2005
    ..Large cohort studies are needed to adequately assess the role of foods and nutrients in cervical HPV carcinogenesis...
  41. doi Dietary factors and in situ and invasive cervical cancer risk in the European prospective investigation into cancer and nutrition study
    Carlos A Gonzalez
    Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Barcelona, Spain
    Int J Cancer 129:449-59. 2011
    ..None of the dietary factors examined was associated with CIS. Our study suggests a possible protective role of fruit intake and other dietary factors on ISC that need to be confirmed on a larger number of ISC cases...
  42. doi Epidemiology and cost of treatment of genital warts in Spain
    Xavier Castellsague
    Cancer Epidemiology Research Program, Institut Catala d Oncologia, IDIBELL, CIBERESP, L Hospitalet de Llobregat, Spain
    Eur J Public Health 19:106-10. 2009
    ..Ninety percent of GW are due to Human Papillomavirus (HPV) types 6 and 11. The objective of this study was to assess the epidemiology and management costs associated with GW in Spain...
  43. pmc Maté drinking and esophageal squamous cell carcinoma in South America: pooled results from two large multicenter case-control studies
    Jay H Lubin
    Authors Affiliations Biostatistics Branch and Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland Epidemiology Group, Department of Pathology Department of Pathology, School of Medicine, University of the Republic Deneo Pellegrini, Director, Department of Pathology, Cancer Institute Unit of Oncology and Radiotherapy, Pereira Rossell Women s Hospital, Montevideo IUCLAEH School of Medicine, Maldonado, Uruguay The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York Post Graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Rio Grande do Sul, Brazil Nubia Muñoz, Cancer Institute of Colombia, Bogota, Colombia Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France and Catalan Institute of Oncology ICO, IDIBELL, CIBERESP, L Hospitalet de Llobregat 08908, Catalonia, Spain
    Cancer Epidemiol Biomarkers Prev 23:107-16. 2014
    ..Maté tea is a nonalcoholic infusion widely consumed in southern South America, and may increase risk of esophageal squamous cell carcinoma (ESCC) and other cancers due to polycyclic aromatic hydrocarbons (PAH) and/or thermal injury...
  44. doi Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial
    Jordi Carratala
    Infectious Disease Service, Bellvitge Institute for Biomedical Research IDIBELL Hospital Universitari de Bellvitge, University of Barcelona, L Hospitalet, Barcelona, Spain
    Arch Intern Med 172:922-8. 2012
    ..We aimed to determine whether the use of a 3-step critical pathway is safe and effective in reducing duration of intravenous antibiotic therapy and length of stay in hospitalized patients with CAP...
  45. ncbi p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach
    Xavier Garcia del Muro
    Department of Medical Oncology, Institut Catala d Oncologia, Barcelona, Spain
    Cancer 100:1859-67. 2004
    ....
  46. ncbi Resource consumption and costs of palliative care services in Spain: a multicenter prospective study
    Xavier Gómez-Batiste
    Palliative Care Service X G B, A T, E C, J P S, J E, and Cancer Epidemiology Unit X C, Institut Catala d Oncologia, Barcelona, Spain
    J Pain Symptom Manage 31:522-32. 2006
    ..6%; P=0.001), and an increase in programmed care. Compared to the previous resource consumption and expenditure study in 1992, the current PCS policy implies a cost saving of 61%, with greater efficiency and no compromise of patient care...